The enhancement of recombinant antibody production in Chinese Hamster Ovary (CHO-K1) cells is a crucial aspect of biopharmaceutical development. To maximize efficacy, various approaches are employed, including genetic engineering of the host cells and optimization of growth conditions. Additionally, implementation of advanced production systems c